Cargando…
Engineering Breast Cancer On-chip—Moving Toward Subtype Specific Models
Breast cancer is the second leading cause of death among women worldwide, and while hormone receptor positive subtypes have a clear and effective treatment strategy, other subtypes, such as triple negative breast cancers, do not. Development of new drugs, antibodies, or immune targets requires signi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261144/ https://www.ncbi.nlm.nih.gov/pubmed/34249889 http://dx.doi.org/10.3389/fbioe.2021.694218 |